XGEVA Solution for Injection 120 mg/vial
Product details
Registration number: SIN14116P
Classification: Prescription Only
Active ingredients: Denosumab
Strength: 120 mg/vial
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD
ATC code: M05BX04
HSA approval date: 2 March 2012
Manufacturer(s): Amgen Manufacturing Limited LLC
Manufacturing country/countries: UNITED STATES
What are the HSA registration number and classification for XGEVA Solution for Injection 120 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14116P
Classification: Prescription Only
What active ingredients and strength are recorded for XGEVA Solution for Injection 120 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Denosumab
Strength: 120 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for XGEVA Solution for Injection 120 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for XGEVA Solution for Injection 120 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD
Which manufacturers and countries are listed for XGEVA Solution for Injection 120 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Amgen Manufacturing Limited LLC
Manufacturing country/countries: UNITED STATES
Where can I look up XGEVA Solution for Injection 120 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14116P or the exact product name XGEVA Solution for Injection 120 mg/vial. The general register link does not preselect this product.
What are the source dates for this XGEVA Solution for Injection 120 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this XGEVA Solution for Injection 120 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14116P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)